The usage guidelines include: Inject it under the skin once weekly, on the same day each week
Phase 1 GLP-1 and GLP-1/GIP receptor agonists should be used as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight maintenance, in: BMI 38 kg/m 2 (or 35 kg/m 2 in ethnic groups known to be at equivalent risk of obesity consequences at lower BMI than White ethnicity), and one or more obesity-related clinical condition, or Edmonton Obesity Staging System stage 3 or 4 (see Box 1
For weight management, NICE has approved specific GLP-1 agonists (Saxenda, Wegovy) under defined criteria
Hodges RE, Minich DM
Glutathione face wash with its rich creamy feel, makes skin soft & supple
Mollica MP, Iossa S, Soboll S, Liverini G (2001) Acetyl-L-carnitine treatment stimulates oxygen consumption and biosynthetic function in perfused liver of young and old rats